LSX USA Congress | Biotech Leaders

Biotech Leaders is part of LSX USA

For the last 9 years, Biotech Leaders has been working with international life science & healthcare decision makers who are leading the next wave of industry innovation.

Our mission is to help them overcome challenges by connecting them with advisors and strategic partners that can help take their innovation from concept to market.

At the heart of the Biotech Leaders network are the founders and CEOs of the world’s most innovative drug discovery and therapeutic start-ups and SMEs.

They are joined by leading health and life science investors from across the USA and Europe and pharma who are on the look out for new innovation, partners and advisors.

Tim Luker

VP, Venture Science, Eli Lilly

Philippe Lopes-Fernandez

EVP & CBO, Ipsen

Monika Vnuk

Global Head, Partnering & BD, Sanofi

Marian Nakada

VP Venture Investment, J&J Innovation

David Moore

SVP, Head Corporate Development, Novo Nordisk

Sander Slootweg,

Managing Partner, Forbion

Gregory Verdine

CEO, Fog Pharma

Beth Shafer

VP & Head, Takeda Business Development

Amanda Murphy

VP Head of External Innovation M&A, Ginkgo Bioworks

Stephen Hahn

CEO-Partner, Flagship Pioneering

Detlev Mennerich

Corporate SVP, Global Head of BD&L, Boehringer Ingelheim

Deborah Palestrant

Partner, 5AM Ventures

5 reasons to choose Biotech Leaders

LSX World Biotech Key Reasons 01

Biotech Leaders @ LSX World Congress USA is America’s largest and most significant Biotech CEO gathering. No other event is exclusively designed to address all the strategic and partnering goals of America’s Biotech CEO ecosystem.

LSX World Biotech Key Reasons 02

Biotech Leaders @ LSX World Congress USA attracts the highest quality speakers from the biggest and best large pharma and life science investment firms. Hear from global BD heads at J&J, Merck, Novo Nordisk, GSK, Eli Lily and Boehringer Ingelheim.

LSX World Biotech Key Reasons 03

No other event offers access to as many highly-qualified, specialist life science investors. LSX World Congress USA will be bringing over 200 of the world’s most active investors to Boston. Fundraising? There’s no better place to be.

LSX World Biotech Key Reasons 04

All biotechs, investors and pharma attendees are qualified during the registration process to ascertain their stage of development, strategic goals, therapeutic preferences, and fundraising/allocation targets. This provides absolute clarity on the issues that matter most to our attendees and allows delegates and partners to identify and target the most qualified prospects through our highly sophisticated 1-2-1 partnering system.

LSX World Biotech Key Reasons 05

As well as partnering, content, showcases and exhibition, Biotech Leaders @ LSX World Congress USA offers a range of smaller group meetings/CEO forums/workshops targeting particular profiles of attendees. This means highly qualified groups of attendees to meet in an interactive and intimate setting and provides you with the opportunity to talk to the people that matter most to you.

ABOUT

LSX is the Life Science eXecutive partnering community.

We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.